Gluckman E - Search Results

1

[Treatment of cytomegalovirus infections in allogeneic bone marrow transplantation].

Devergie A, Traineau R, Lehn P, Jolivet I, Quessar A, Esperou-Bourdeau H, Mazeron MC, Bussel A, Gluckman E. Devergie A, et al. Among authors: gluckman e. Rev Fr Transfus Hemobiol. 1991 Oct;34(5):395-402. doi: 10.1016/s1140-4639(05)80215-1. Rev Fr Transfus Hemobiol. 1991. PMID: 1663357 Review. French. No abstract available.

2

Prevention and treatment of CMV infection after allogeneic bone marrow transplant.

Gluckman E, Traineau R, Devergie A, Esperou-Bourdeau H, Hirsch I. Gluckman E, et al. Ann Hematol. 1992 Jun;64 Suppl:A158-61. doi: 10.1007/BF01715372. Ann Hematol. 1992. PMID: 1322189

3

Influence of various conditioning regimens on the outcome of bone marrow transplantation for leukemia.

Devergie A, Socie G, Esperou-Bourdeau H, Ribaud P, Traineau R, Gluckman E. Devergie A, et al. Among authors: gluckman e. Nouv Rev Fr Hematol (1978). 1991;33(6):437-9. Nouv Rev Fr Hematol (1978). 1991. PMID: 1818295 Review.

4

Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation.

Gluckman E, Jolivet I, Scrobohaci ML, Devergie A, Traineau R, Bourdeau-Esperou H, Lehn P, Faure P, Drouet L. Gluckman E, et al. Br J Haematol. 1990 Mar;74(3):277-81. doi: 10.1111/j.1365-2141.1990.tb02583.x. Br J Haematol. 1990. PMID: 2159315

5

Role of PGE1 to prevent veno-occlusive disease of the liver after bone marrow transplantation.

Gluckman E, Jolivet I, Scrobohaci ML, Devergie A, Traineau R, Bourdeau-Espérou H, Lehn P, Faure P, Drouet L. Gluckman E, et al. Nouv Rev Fr Hematol (1978). 1990;32(1):1-3. Nouv Rev Fr Hematol (1978). 1990. PMID: 2349075

6

Role of immunosuppressive drugs for prevention of graft-v-host disease after bone marrow transplantation.

Devergie A, Esperou H, Traineau R, Varrin F, Lehn P, Gluckman E. Devergie A, et al. Among authors: gluckman e. Nouv Rev Fr Hematol (1978). 1989;31(2):73-5. Nouv Rev Fr Hematol (1978). 1989. PMID: 2671932 Clinical Trial.

7

Malignant diseases after allogeneic bone marrow transplantation: an updated overview.

Socié G, Henry-Amar M, Devergie A, Esperou-Bourdeau H, Ribaud P, Traineau R, Gluckman E. Socié G, et al. Among authors: gluckman e. Nouv Rev Fr Hematol (1978). 1994;36 Suppl 1:S75-7. Nouv Rev Fr Hematol (1978). 1994. PMID: 8177721 Review.

8

Progress in the prevention of cytomegalovirus infection after allogeneic bone marrow transplantation.

Devergie A, Traineau R, Esperou-Bourdeau H, Ribaud P, Socié G, Richard P, Selimi F, Hirsch I, Gluckman E. Devergie A, et al. Among authors: gluckman e. Nouv Rev Fr Hematol (1978). 1994;36 Suppl 1:S89-90. Nouv Rev Fr Hematol (1978). 1994. PMID: 8177726

9

[Secondary neoplasms after allograft of bone marrow. Role of irradiation].

Socié G, Devergie A, Cosset JM, Gluckman E. Socié G, et al. Among authors: gluckman e. Bull Cancer. 1992;79(4):383-5. Bull Cancer. 1992. PMID: 1421700 French. No abstract available.

10

Poor clinical outcome of patients developing malignant solid tumors after bone marrow transplantation for severe aplastic anemia.

Socié G, Henry-Amar M, Devergie A, Wibault P, Neiger M, Cosset JM, Gluckman E. Socié G, et al. Among authors: gluckman e. Leuk Lymphoma. 1992 Aug;7(5-6):419-23. doi: 10.3109/10428199209049797. Leuk Lymphoma. 1992. PMID: 1493443

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

804 results

Search Page

Filters